Amylin levels in migraine patients on anti-CGRP treatment
Part of Brain & nervous system clinical trials.
This study looks at a substance called amylin in the blood of people with migraine, before and during treatment with a new type of medication that blocks a protein linked to migraine pain. It aims to see if amylin levels change with treatment and might help us understand how well the medication works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with either high-frequency episodic migraine (lots of migraine days but not every day) or chronic migraine (15 or more headache days per month).
- Your doctor has prescribed a type of migraine medication called an anti-CGRP monoclonal antibody (a shot or infusion that targets a protein related to migraine).
- You have not yet started taking this medication.
- You are 18 years old or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a natural substance called amylin can trigger migraine attacks in people who get migraines without aura. If you join, you'll receive an infusion and be monitored to see if you get a migraine, which could help researchers understand migraine causes.
This study tests a CGRP-blocking antibody to see how it affects migraine symptoms and the body’s automatic (involuntary) nerve functions. It may help people with migraine who have already tried several preventive medicines.
This study is building a database to learn more about migraine drugs. It may help researchers find better treatments for people with episodic or chronic migraine.
This trial tests a substance that activates adrenomedullin receptors, which may be a new way to treat migraines. It may help people who have migraines without aura and aren't on preventive migraine medications.
This study measures a substance called CGRP in saliva from people with migraine and healthy volunteers to see how it changes with age and sex. It may help researchers understand migraine better.
This study looks at blood samples from people with migraine to find proteins and other markers that might explain why migraines happen. The goal is to better understand migraine, which could help find better treatments in the future.
Hear when a new High Frequency Episodic Migraine and Chronic Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.